Poxel/Sumitomo's Novel Diabetes Therapy Imeglimin Nears Japan Market

A Phase III-Ready Partnering Opportunity For EU/US

 
• By John Davis
  
mitochondria
Imeglimin Targets Mitochondria Dysfunction • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas